The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Dimitrios P. Kontoyiannis

Division of Internal Medicine

Department of Infectious Diseases Infection Control and Employee Health

The University of Texas MD Anderson Cancer Center

Houston

USA

[email]@mdanderson.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Internal Medicine, Department of Infectious Diseases Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, USA. 2002 - 2012
  • Department of Internal Medicine, School of Medicine, University of Crete, Heraklion, Greece. 2011
  • The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 2010
  • M. D. Anderson Cancer Center, University of Texas, Houston, Texas 77030-3930, USA. 2008

References

  1. Invasive mycoses: strategies for effective management. Kontoyiannis, D.P. Am. J. Med. (2012) [Pubmed]
  2. Drosophila melanogaster as a Model Host for the Study of Microbial Pathogenicity and the Discovery of Novel Antimicrobial Compounds. Chamilos, G., Samonis, G., Kontoyiannis, D.P. Curr. Pharm. Des. (2011) [Pubmed]
  3. Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success. Kontoyiannis, D.P. Bone Marrow Transplant. (2011) [Pubmed]
  4. Manipulation of host angioneogenesis: A critical link for understanding the pathogenesis of invasive mold infections? Kontoyiannis, D.P. Virulence (2010) [Pubmed]
  5. Caspofungin-non-susceptible Candida isolates in cancer patients. Kofteridis, D.P., Lewis, R.E., Kontoyiannis, D.P. J. Antimicrob. Chemother. (2010) [Pubmed]
  6. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Kontoyiannis, D.P., Marr, K.A., Park, B.J., Alexander, B.D., Anaissie, E.J., Walsh, T.J., Ito, J., Andes, D.R., Baddley, J.W., Brown, J.M., Brumble, L.M., Freifeld, A.G., Hadley, S., Herwaldt, L.A., Kauffman, C.A., Knapp, K., Lyon, G.M., Morrison, V.A., Papanicolaou, G., Patterson, T.F., Perl, T.M., Schuster, M.G., Walker, R., Wannemuehler, K.A., Wingard, J.R., Chiller, T.M., Pappas, P.G. Clin. Infect. Dis. (2010) [Pubmed]
  7. Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis. Kontoyiannis, D.P., Ratanatharathorn, V., Young, J.A., Raymond, J., Laverdière, M., Denning, D.W., Patterson, T.F., Facklam, D., Kovanda, L., Arnold, L., Lau, W., Buell, D., Marr, K.A. Transpl. Infect. Dis (2009) [Pubmed]
  8. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Kontoyiannis, D.P., Lewis, R.E., Alexander, B.D., Lortholary, O., Dromer, F., Gupta, K.L., John, G.T., Del Busto, R., Klintmalm, G.B., Somani, J., Lyon, G.M., Pursell, K., Stosor, V., Munoz, P., Limaye, A.P., Kalil, A.C., Pruett, T.L., Garcia-Diaz, J., Humar, A., Houston, S., House, A.A., Wray, D., Orloff, S., Dowdy, L.A., Fisher, R.A., Heitman, J., Albert, N.D., Wagener, M.M., Singh, N. Antimicrob. Agents Chemother. (2008) [Pubmed]
  9. Decrease in the number of reported cases of zygomycosis among patients with diabetes mellitus: a hypothesis. Kontoyiannis, D.P. Clin. Infect. Dis. (2007) [Pubmed]
  10. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Kontoyiannis, D.P., Chamilos, G., Lewis, R.E., Giralt, S., Cortes, J., Raad, I.I., Manning, J.T., Han, X. Cancer (2007) [Pubmed]
  11. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Kontoyiannis, D.P., Lewis, R.E. Infect. Dis. Clin. North Am. (2006) [Pubmed]
  12. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. Kontoyiannis, D.P., Lionakis, M.S., Lewis, R.E., Chamilos, G., Healy, M., Perego, C., Safdar, A., Kantarjian, H., Champlin, R., Walsh, T.J., Raad, I.I. J. Infect. Dis. (2005) [Pubmed]
  13. Sinus zygomycosis in a patient receiving voriconazole prophylaxis. Lionakis, M.S., Kontoyiannis, D.P. Br. J. Haematol. (2005) [Pubmed]
  14. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Kontoyiannis, D.P., Boktour, M., Hanna, H., Torres, H.A., Hachem, R., Raad, I.I. Cancer (2005) [Pubmed]
  15. Outcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recovery. Kontoyiannis, D.P., Bodey, G.P., Hanna, H., Hachem, R., Boktour, M., Girgaway, E., Mardani, M., Raad, I.I. Leuk. Lymphoma (2004) [Pubmed]
  16. Toward more effective antifungal therapy: the prospects of combination therapy. Kontoyiannis, D.P., Lewis, R.E. Br. J. Haematol. (2004) [Pubmed]
  17. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Kontoyiannis, D.P., Torres, H.A., Chagua, M., Hachem, R., Tarrand, J.J., Bodey, G.P., Raad, I.I. Scand. J. Infect. Dis. (2004) [Pubmed]
  18. Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. Kontoyiannis, D.P., Lewis, R.E., Osherov, N., Albert, N.D., May, G.S. J. Antimicrob. Chemother. (2003) [Pubmed]
  19. Systemic mycoses in the immunocompromised host: an update in antifungal therapy. Kontoyiannis, D.P., Mantadakis, E., Samonis, G. J. Hosp. Infect. (2003) [Pubmed]
  20. What is the significance of an isolated positive cryptococcal antigen in the cerebrospinal fluid of cancer patients?. Kontoyiannis, D.P. Mycoses (2003) [Pubmed]
  21. Fluconazole toxicity is independent of oxidative stress and apoptotic effector mechanisms in Saccharomyces cerevisiae. Kontoyiannis, D.P., Murray, P.J. Mycoses (2003) [Pubmed]
  22. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Kontoyiannis, D.P., Hachem, R., Lewis, R.E., Rivero, G.A., Torres, H.A., Thornby, J., Champlin, R., Kantarjian, H., Bodey, G.P., Raad, I.I. Cancer (2003) [Pubmed]
  23. Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity. Kontoyiannis, D.P., Lewis, R.E., Lionakis, M.S., Albert, N.D., May, G.S., Raad, I.I. Diagn. Microbiol. Infect. Dis. (2003) [Pubmed]
  24. Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far. Kontoyiannis, D.P., Lewis, R.E. Drug Resist. Updat. (2003) [Pubmed]
  25. Pulmonary candidiasis in patients with cancer: an autopsy study. Kontoyiannis, D.P., Reddy, B.T., Torres, H.A., Luna, M., Lewis, R.E., Tarrand, J., Bodey, G.P., Raad, I.I. Clin. Infect. Dis. (2002) [Pubmed]
  26. Antifungal drug resistance of pathogenic fungi. Kontoyiannis, D.P., Lewis, R.E. Lancet (2002) [Pubmed]
  27. Invasive aspergillosis in 2002: an update. Kontoyiannis, D.P., Bodey, G.P. Eur. J. Clin. Microbiol. Infect. Dis. (2002) [Pubmed]
 
WikiGenes - Universities